Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial
Top Cited Papers
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9340) , 1119-1125
- https://doi.org/10.1016/s0140-6736(02)11196-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjectsTransplantation, 2002
- Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 yearsLiver Transplantation, 2001
- RANDOMIZED TRIAL OF CYCLOSPORINE MICROEMULSION (NEORAL) VERSUS CONVENTIONAL CYCLOSPORINE IN LIVER TRANSPLANTATIONTransplantation, 1998
- Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †Hepatology, 1998
- A LONG-TERM COMPARISON OF TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN LIVER TRANSPLANTATION1Transplantation, 1998
- Defining the outcome of immunosuppression withdrawal after liver transplantationHepatology, 1998
- Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin ABritish Journal of Pharmacology, 1997
- Two-year data from the European multicentre tacrolimus (F 06) liver studyTransplant International, 1996
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994